Marieke van Son

77 FOCAL SALVAGE TREATMENT: A NARRATIVE REVIEW 22. Cellini, N.; Morganti, A.G.; Mattiucci, G.C.; Valentini, V.; Leone, M.; Luzi, S.; Manfre- di, R.; Dinapoli, N.; Digesu, C.; Smaniotto, D. Analysis of intraprostatic failures in patients treated with hormonal therapy and radiotherapy: Implications for con- formal therapy planning. Int J Radiat Oncol Biol Phys 2002, 53, 595-599. 23. Chopra, S.; Toi, A.; Taback, N.; Evans, A.; Haider, M.A.; Milosevic, M.; Bristow, R.G.; Chung, P.; Bayley, A.; Morton, G., et al. Pathological predictors for site of local recurrence after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2012, 82, e441-448; DOI: 10.1016/j. ijrobp.2011.05.035. 24. Pucar, D.; Hricak, H.; Shukla-Dave, A.; Kuroiwa, K.; Drobnjak, M.; Eastham, J.; Scardino, P.T.; Zelefsky, M.J. Clinically significant prostate cancer local re- currence after radiation therapy occurs at the site of primary tumor: Magnetic resonance imaging and step-section pathology evidence. Int J Radiat Oncol Biol Phys 2007, 69, 62-69; DOI: 10.1016/j. ijrobp.2007.03.065. 25. Jalloh, M.; Leapman, M.S.; Cowan, J.E.; Shinohara, K.; Greene, K.L.; Roach, M., 3rd; Chang, A.J.; Chan, J.M.; Simko, J.P.; Carroll, P.R. Patterns of local failure fol- lowing radiation therapy for prostate cancer. The Journal of urology 2015, 194, 977-982; DOI: 10.1016/j.juro.2015.04.111. 26. Chade, D.C.; Eastham, J.; Graefen, M.; Hu, J.C.; Karnes, R.J.; Klotz, L.; Montorsi, F.; van Poppel, H.; Scardino, P.T.; Shariat, S.F. Cancer control and functional out- comes of salvage radical prostatectomy for radiation-recurrent prostate cancer: A systematic review of the literature. Eur Urol 2012, 61, 961-971; DOI: 10.1016/j. eururo.2012.01.022. 27. Wenske, S.; Quarrier, S.; Katz, A.E. Sal- vage cryosurgery of the prostate for failure after primary radiotherapy or cryosurgery: Long-term clinical, func- tional, and oncologic outcomes in a large cohort at a tertiary referral centre. Eur Urol 2013, 64, 1-7; DOI: 10.1016/j. eururo.2012.07.008. 28. Williams, A.K.; Martinez, C.H.; Lu, C.; Ng, C.K.; Pautler, S.E.; Chin, J.L. Disease-free survival following salvage cryotherapy for biopsy-proven radio-recurrent pros- tate cancer. Eur Urol 2011, 60, 405-410; DOI: 10.1016/j.eururo.2010.12.012. 29. Murat, F.J.; Poissonnier, L.; Rabilloud, M.; Belot, A.; Bouvier, R.; Rouviere, O.; Chapelon, J.Y.; Gelet, A. Mid-term results demonstrate salvage high-intensity fo- cused ultrasound (hifu) as an effective and acceptably morbid salvage treat- ment option for locally radiorecurrent prostate cancer. Eur Urol 2009, 55, 640- 647; DOI: 10.1016/j.eururo.2008.04.091. 30. Crouzet, S.; Murat, F.J.; Pommier, P.; Poissonnier, L.; Pasticier, G.; Rouviere, O.; Chapelon, J.Y.; Rabilloud, M.; Belot, A.; Mege-Lechevallier, F., et al. Local- ly recurrent prostate cancer after ini- tial radiation therapy: Early salvage high-intensity focused ultrasound im- proves oncologic outcomes. Radiother Oncol 2012, 105, 198-202; DOI: 10.1016/j. radonc.2012.09.014. 31. Chen, C.P.; Weinberg, V.; Shinohara, K.; Roach, M., 3rd; Nash, M.; Gottschalk, A.; Chang, A.J.; Hsu, I.C. Salvage hdr brachytherapy for recurrent prostate cancer after previous definitive radiation therapy: 5-year outcomes. Int J Radiat Oncol Biol Phys 2013, 86, 324-329; DOI: 10.1016/j.ijrobp.2013.01.027. 32. Kollmeier, M.A.; McBride, S.; Taggar, A.; Anderson, E.; Lin, M.; Pei, X.; Weiji, S.; Voros, L.; Cohen, G.; Yamada, Y., et al. Salvage brachytherapy for recurrent prostate cancer after definitive radiation therapy: A comparison of low-dose-rate and high-dose-rate brachytherapy and the importance of prostate-specific antigen doubling time. Brachythera- py 2017, 16, 1091-1098; DOI: 10.1016/j. brachy.2017.07.013. 4